Law Firm | Canadian Lawyer

Goodwin Procter LLP

19 Nov 2024

AeroVironment to Acquire BlueHalo

Deal TypeMerger & Acquisition

IndustryTech/Computer/IT

Transaction Value$ 4,100,000,000

ClientsAeroVironment, Inc., BlueHalo LLC
8 Oct 2024

Cardiol Therapeutics announces new public offering of Class A Shares

Deal TypePublic/Private Offering

IndustryHealthcare

Transaction ValueUndisclosed/Confidential

ClientsCardiol Therapeutics Inc., Canaccord Genuity LLC, Canaccord Genuity Corp.
7 Oct 2024

Virios Therapeutics and Wex Pharmaceuticals merge to form Dogwood Therapeutics

Deal TypeMerger & Acquisition

IndustryHealthcare

Transaction Value$ 143,000,000

ClientsVirios Therapeutics, Inc., Wex Pharmaceuticals, CK Life Sciences Int’l.
16 Sep 2024

Vizsla Silver closes $65 million public offering

Deal TypePublic/Private Offering

IndustryMining

Transaction Value$ 65,000,000

ClientsVizsla Silver Corp., Canaccord Genuity Corp., CIBC World Markets Inc., Ventum Financial Corp., Raymond James Ltd., Stifel Nicolaus Canada Inc., National Bank Financial Inc., BMO Nesbitt Burns Inc.
17 Jun 2024

TowerBrook Delta acquires LiftWerx

Deal TypeMerger & Acquisition

IndustryEnergy

Transaction ValueUndisclosed/Confidential

ClientsTowerBrook Capital Partners L.P., LiftWerx Solutions
30 May 2024

Cansortium Inc. to acquire RIV Capital Inc. in major cannabis industry merger

Deal TypeMerger & Acquisition

IndustryOther

Transaction ValueUndisclosed/Confidential

ClientsCansortium Inc., RIV Capital Inc., Agent and Required Lenders
10 Apr 2024

Galaxy Digital Holdings raises $169.4 million in share offering

Deal TypePublic/Private Offering

IndustryBanking/Finance

Transaction Value$ 169,400,000

ClientsGalaxy Digital Holdings Ltd., Canaccord Genuity Corp., Jefferies Securities, Inc., Stifel Nicolaus Canada Inc.
19 Mar 2024

AstraZeneca acquires Fusion Pharmaceuticals for $2.4 billion, bolstering oncology portfolio with radioconjugate innovations

Deal TypeMerger & Acquisition

IndustryHealthcare

Transaction Value$ 2,400,000,000

ClientsAstraZeneca, Fusion Pharmaceuticals Inc.
5 Mar 2024

AGA Benefit Solutions secures growth investment from TA Associates

Deal TypeFinancing/Investment

IndustryBanking/Finance

Transaction ValueUndisclosed/Confidential

ClientsAGA Benefit Solutions, TA Associates
5 Feb 2024

Novo Holdings to acquire Catalent in $22.2 billion all-cash deal

Deal TypeMerger & Acquisition

IndustryHealthcare

Transaction Value$ 22,200,000,000

ClientsNovo Holdings, Catalent, Inc.